GNC Shareholder Alert: Kessler Topaz Meltzer & Check LLP

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
GNC Shareholder Alert: Kessler Topaz Meltzer & Check LLP Notifies GNC Shareholders of Expanded Class Period in Class Action

RADNOR, PA --(Marketwired - December 02, 2015) - The law firm of Kessler Topaz Meltzer & Check, LLP announces that a shareholder class action lawsuit has been filed in United States District Court for the Western District of Pennsylvania against GNC Holdings, Inc. ( NYSE : GNC ) ("GNC" or the Company") on behalf of purchasers of the Company's securities between November 28, 2011 and October 28, 2015 , inclusive (the "Class Period").

For additional information about the shareholder lawsuit, or to request information about the action online, please visit http://www.ktmc.com/new-cases/gnc-holdings-inc .

The shareholder class action lawsuit alleges that GNC and certain of its executive officers made a series of false and misleading statements during the Class Period, and failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, the defendants are alleged to have made materially false and misleading statements to investors and/or failed to disclose that: (1) GNC unlawfully sold thousands of units of products in Oregon that contained picamilon; (2) GNC unlawfully sold thousands of units of products in Oregon that contained BMPEA; and (3) as a result of the foregoing, the Company's public statements were materially false and misleading at all relevant times.

On October 22, 2015, the Attorney General of Oregon sued GNC alleging that it sold "nutritional and dietary supplements containing the illegal ingredients picamilon and BMPEA." Among other things, the Attorney General alleged that GNC was "misrepresenting certain products as lawful dietary supplements when they are actually unapproved drugs that may not be lawfully sold in the United States as a dietary supplement."

On this news, shares of GNC's common stock declined $5.73 per share, or more than 14%, to close on October 22, 2015 at $34.50 per share.

Shareholder Update : October 29, 2015, GNC issued a press release announcing disappointing Third Quarter 2015 financial results. For the quarter, GNC reported a 29% drop in profit and a $28.3 million asset impairment charge associated with its Discount Supplements line of business. On this additional news, shares of GNC's common stock declined an additional $10.40 per share, or nearly 27%, to close on October 29, 2015 at $28.24 per share.

If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check (Darren J. Check, Esq., D. Seamus Kaskela, Esq. or Adrienne O. Bell, Esq.) at (888) 299 - 7706 or (610) 667 - 7706, or via e-mail at info@ktmc.com .

GNC shareholders who purchased their securities during the Class Period may, no later than December 28, 2015, petition the Court to be appointed as a lead plaintiff of the class.

A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. In order to be appointed as a lead plaintiff, the Court must determine that the class member's claim is typical of the claims of other class members, and that the class member will adequately represent the class in the action. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff. Any member of the purported class may move the court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.

Kessler Topaz Meltzer & Check prosecutes class actions in state and federal courts throughout the country. Kessler Topaz Meltzer & Check is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world. The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars). The complaint in this action was not filed by Kessler Topaz Meltzer & Check. For more information about Kessler Topaz Meltzer & Check, or for additional information about participating in this action, please visit www.ktmc.com .

CONTACT: Kessler Topaz Meltzer & Check, LLP Darren J. Check, Esq. D. Seamus Kaskela, Esq. Adrienne O. Bell, Esq. 280 King of Prussia Road Radnor, PA 19087 (888) 299 - 7706 (610) 667 - 7706 info@ktmc.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating the Pioneers: Results of the 2025 Belonging Awards

Updated Category News Views 242

Introduction to the 2025 Belonging Awards The 2025 Belonging Awards stand as a testament to organizations dedicated to fostering an inclusive workplace. This year, the awards, organized by the Employer Branding Institute, saw a remarkable competition among companies globally, showcasing their commitment to Diversity, Equity, and Inclusion (DEI). The extensive evaluation...

Continue Reading
AI Innovations Driving Growth in Hypothyroidism Market

Updated Category News Views 183

The Growing Hypothyroidism Market and Its Innovations The global hypothyroidism market is on the brink of significant expansion, with projections indicating a remarkable growth of USD 789.8 million over the upcoming years. This growth is fueled by innovative advancements and strategic approaches within the healthcare sector. The market is expected to exhibit an impressive...

Continue Reading
Richmond Heights Celebrates 75 Years with Inspiring Stories

Updated Category News Views 273

Celebating 75 Years of Richmond Heights The Richmond Heights community recently came together for a significant milestone, marking 75 years of rich history and cultural diversity. The celebration was not only about the past; it was a heartfelt acknowledgment of the leaders who have molded this extraordinary place over decades. A Tribute to Community Leaders This special...

Continue Reading
Investigation Launched into Dyne Therapeutics Over Stock Drop

Updated Category News Views 82

Investigation Launched into Dyne Therapeutics Following Stock Decline Dyne Therapeutics, Inc. (NASDAQ: DYN), recognized for its groundbreaking approaches to treating muscular dystrophy, is currently facing scrutiny as Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into potential claims on behalf of investors. This action follows some concerning news...

Continue Reading
Taseko Mines: Highlights from Q1 Earnings Report and Future Plans

Updated Category News Views 211

Insight into Taseko Mines Limited's Q1 2025 Performance Taseko Mines Limited (TSX: TKO; NYSE American: TGB; LSE: TKO), based in Vancouver, British Columbia, is making waves in the mining sector with its compelling first quarter earnings report for 2025. The company disclosed an Adjusted EBITDA of $34 million and earnings from mining operations before depletion and...

Continue Reading